Quantum-Si incorporated (NASDAQ:QSI – Get Free Report) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 20,570,000 shares, a growth of 23.6% from the March 15th total of 16,640,000 shares. Based on an average trading volume of 13,130,000 shares, the short-interest ratio is presently 1.6 days. Approximately 15.4% of the company’s stock are sold short.
Quantum-Si Stock Down 5.2 %
NASDAQ QSI opened at $1.09 on Tuesday. The company’s 50 day moving average is $1.38 and its 200-day moving average is $1.53. The firm has a market cap of $199.62 million, a P/E ratio of -1.70 and a beta of 2.71. Quantum-Si has a 12-month low of $0.61 and a 12-month high of $5.77.
Insider Activity at Quantum-Si
In other news, CEO Jeffrey Alan Hawkins sold 23,707 shares of the firm’s stock in a transaction that occurred on Friday, March 21st. The stock was sold at an average price of $1.39, for a total value of $32,952.73. Following the transaction, the chief executive officer now owns 2,646,716 shares in the company, valued at $3,678,935.24. This trade represents a 0.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have sold 36,650 shares of company stock worth $50,944 in the last quarter. Company insiders own 30.04% of the company’s stock.
Hedge Funds Weigh In On Quantum-Si
Wall Street Analyst Weigh In
QSI has been the topic of a number of research analyst reports. Alliance Global Partners restated a “buy” rating on shares of Quantum-Si in a research note on Wednesday, March 5th. HC Wainwright reiterated a “buy” rating and issued a $5.50 target price on shares of Quantum-Si in a research note on Tuesday, January 14th. Finally, National Bankshares set a $3.65 price target on shares of Quantum-Si in a report on Wednesday, March 5th.
Read Our Latest Research Report on QSI
Quantum-Si Company Profile
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Read More
- Five stocks we like better than Quantum-Si
- What is a SEC Filing?
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- Dividend Payout Ratio Calculator
- Why Call Option Traders Are Targeting This Dividend ETF Now
- Using the MarketBeat Dividend Yield Calculator
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.